Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study

J Tabernero, E Van Cussem, Y Bang, C Fuchs, L Wyrwicz, K Lee, I Kudaba, M Garrido, C Chung, CC Salguero, W Mansoor, M Braghiroli, E Goekkurt, J Chao, Z Wainberg, U Kher, S Shah, S Karg, K Shitara

Research output: Contribution to journalMeeting Abstractpeer-review

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this